Explorez tous les épisodes du podcast CEimpact Podcast
Plongez dans la liste complète des épisodes de CEimpact Podcast. Chaque épisode est catalogué accompagné de descriptions détaillées, ce qui facilite la recherche et l'exploration de sujets spécifiques. Suivez tous les épisodes de votre podcast préféré et ne manquez aucun contenu pertinent.
Rows per page:
50
1–50 of 397
Titre
Date
Durée
Changes in Testosterone Therapy
05 Oct 2026
00:41:37
Testosterone therapy remains a frequently discussed and often controversial topic in patient care. This course reviews current perspectives on testosterone therapy, including potential benefits, safety considerations, monitoring recommendations, and areas of ongoing debate. You will be better prepared to interpret the evidence and support the safe and appropriate use of testosterone therapy in clinical practice.
GUEST Michael Nagy, PharmD Clinical Pharmacy Practitioner Tomah VAMC
GET CE FOR LISTENING! Stay Compliant. Grow Clinically. Practice with Confidence.
Purchase a CE Subscription to get CE credit for this episode.
All episodes, CE, and Practice Resources for the GameChangers Clinical Update are included with a Pharmacist or Technician CE Subscription. But wait…there’s even more!
The Pharmacist & Technician CE Subscriptions include: - Compliance and licensure CE - GameChangers Clinical Updates - Practical continuing education across patient care topics
*The subscription does not include microcredentials or certificates, which are available separately for pharmacists seeking specialized service training.
PRACTICE RESOURCE Receive the exclusive Practice Resource to use as a reference guide for this episode by purchasing a Pharmacist or Technician CE Subscription.
CPE REDEMPTION This course is accredited for continuing pharmacy education!
If you have a CE Subscription and are ready to claim credit, click the link below for your practice role:
If you do not have a CE Subscription, click here to purchase and claim credit for this episode!
CPE INFORMATION Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Describe current indications, potential benefits, and safety considerations associated with testosterone therapy. 2. Identify evidence-based considerations for patient selection, monitoring, and safe use of testosterone therapy.
Rachel Maynard and Michael Nagey have no relevant financial relationships to disclose.
0.075 CEU/0.75 Hr UAN: 0107-0000-26-339-H01-P Initial release date: 10/5/2026 Expiration date: 10/5/2029 Additional CPE details can be found here for pharmacists and here for pharmacy technicians.
New medication approvals continue to expand treatment options across a wide range of disease states, making it essential for pharmacists to stay current with emerging therapies. This course reviews select medications approved within the past year, emphasizing their clinical applications, therapeutic roles, and important safety considerations. You will be better prepared to asse
GUEST Joe Strain, Pharm.D Professor Pharmacy Practice South Dakota State University/Monument Health
GET CE FOR LISTENING! Stay Compliant. Grow Clinically. Practice with Confidence.
Pharmacist CE Subscription: All your CE in one convenient subscription. All episodes, CE, and Practice Resources for the GameChangers Clinical Update is included with your Pharmacist CE Subscription. But wait…there’s even more!
The Pharmacist CE Subscription includes: - Compliance and licensure CE - GameChangers Clinical Updates - Practical continuing education across patient care topics
*The subscription does not include microcredentials or certificates, which are available separately for pharmacists seeking specialized service training.
PRACTICE RESOURCE Receive the exclusive Practice Resource to use as a reference guide for this episode by purchasing the Pharmacist CE Subscription.
CPE REDEMPTION This course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation to claim credit:
CPE INFORMATION Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Describe the mechanisms of action, approved indications, and therapeutic roles of select newly approved medications. 2. Identify key safety, monitoring, and patient-use considerations associated with featured new therapies.
Rachel Maynard and Joe Strain have no relevant financial relationships to disclose.
0.1 CEU/1.0 Hr UAN: 0107-0000-26-338-H01-P Initial release date: 9/28/2026 Expiration date: 9/28/2029 Additional CPE details can be found here.
The Top Five FAQs About Fertility and Reproductive Health
21 Sep 2026
00:57:02
Questions about fertility and reproductive health are increasingly common in pharmacy practice, requiring pharmacists to provide accurate, evidence-based information across a range of patient concerns. This course uses a "Top Five FAQs" format to address common fertility questions, including the impact of obesity and weight-loss medications, fertility preservation strategies, advances in fertility treatment, and other timely reproductive health topics. You will be better prepared to answer patient questions and provide evidence-based counseling on fertility and reproductive health.
GUEST Alexis Ireland, PharmD Doctor University of Iowa Healthcare
GET CE FOR LISTENING! Stay Compliant. Grow Clinically. Practice with Confidence.
Pharmacist CE Subscription: All your CE in one convenient subscription. All episodes, CE, and Practice Resources for the GameChangers Clinical Update is included with your Pharmacist CE Subscription. But wait…there’s even more!
The Pharmacist CE Subscription includes: - Compliance and licensure CE - GameChangers Clinical Updates - Practical continuing education across patient care topics
*The subscription does not include microcredentials or certificates, which are available separately for pharmacists seeking specialized service training.
PRACTICE RESOURCE Receive the exclusive Practice Resource to use as a reference guide for this episode by purchasing the Pharmacist CE Subscription.
CPE REDEMPTION This course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation to claim credit:
CPE INFORMATION Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Describe factors that can influence fertility, including medications, medical conditions, and lifestyle considerations. 2. Explain evidence-based counseling considerations related to fertility preservation, fertility treatment options, and reproductive health.
Rachel Maynard and [Speaker] have no relevant financial relationships to disclose.
0.1 CEU/1.0 Hr UAN: 0107-0000-26-324-H01-P Initial release date: 9/21/2026 Expiration date: 9/21/2029 Additional CPE details can be found here.
GLP-1 receptor agonists remain an important and rapidly changing area of pharmacy practice, with new therapies, expanding indications, and evolving safety considerations shaping patient care. This course reviews recent developments in GLP-1 therapy, including newly approved medications, emerging evidence related to nutrition and oral health, and practical considerations for patient counseling and long-term management. You will be better prepared to evaluate new evidence, counsel patients on the safe and effective use of GLP-1 therapies, and incorporate recent updates into clinical practice.
GUEST Jennifer D. Goldman, PharmD, CDCES, BC-ADM, FCCP Professor of Pharmacy Practice/Director of Cardiometabolic Services Massachusetts College of Pharmacy-Boston, Well Life Medical
GET CE FOR LISTENING! Stay Compliant. Grow Clinically. Practice with Confidence.
Pharmacist CE Subscription: All your CE in one convenient subscription. All episodes, CE, and Practice Resources for the GameChangers Clinical Update is included with your Pharmacist CE Subscription. But wait…there’s even more!
The Pharmacist CE Subscription includes: - Compliance and licensure CE - GameChangers Clinical Updates - Practical continuing education across patient care topics
*The subscription does not include microcredentials or certificates, which are available separately for pharmacists seeking specialized service training.
PRACTICE RESOURCE Receive the exclusive Practice Resource to use as a reference guide for this episode by purchasing the Pharmacist CE Subscription.
CPE REDEMPTION This course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation to claim credit:
CPE INFORMATION Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Describe recent developments in GLP-1 therapies, including newly approved medications. 2. Explain pharmacist-relevant considerations for counseling, safety monitoring, and long-term management of patients receiving GLP-1 therapies.
Jennifer Goldman is a member of the speakers bureau for Novo Nordisk, Amgen, Lilly, Xeris, CeQur, and Abbott Diabetes. All relevant financial relationships have been mitigated.
0.075 CEU/0.75 Hr UAN: 0107-0000-26-323-H01-P Initial release date: 9/14/2026 Expiration date: 9/14/2029 Additional CPE details can be found here.
Using the KIDs List to Improve Pediatric Medication Safety
07 Sep 2026
00:38:47
Children are at increased risk for medication-related harm because of developmental differences, frequent off-label medication use, and unique adverse effect profiles. The Pediatric Pharmacy Association’s updated KIDs List identifies medications and excipients that should be avoided or used with caution in pediatric patients, providing pharmacists with an evidence-based tool to support safer prescribing and medication use. This course reviews key updates from the 2025 KIDs List and discusses practical strategies pharmacists can use to identify risks, recommend safer alternatives, and improve medication safety for pediatric patients.
GUEST Rachel Meyers, PharmD, BCPS, BCPPS Clinical Professor / Pediatric Clinical Pharmacist Ernest Mario School of Pharmacy, Rutgers University / Cooperman Barnabas Medical Center
GET CE FOR LISTENING! Stay Compliant. Grow Clinically. Practice with Confidence.
Pharmacist CE Subscription: All your CE in one convenient subscription. All episodes, CE, and Practice Resources for the GameChangers Clinical Update is included with your Pharmacist CE Subscription. But wait…there’s even more!
The Pharmacist CE Subscription includes: - Compliance and licensure CE - GameChangers Clinical Updates - Practical continuing education across patient care topics
*The subscription does not include microcredentials or certificates, which are available separately for pharmacists seeking specialized service training.
PRACTICE RESOURCE Receive the exclusive Practice Resource to use as a reference guide for this episode by purchasing the Pharmacist CE Subscription.
CPE REDEMPTION This course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation to claim credit:
CPE INFORMATION Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Describe key medications and excipients included in the 2025 KIDs List and the pediatric safety concerns associated with their use. 2. Identify opportunities for pharmacists to apply KIDs List recommendations when evaluating medication therapy and counseling caregivers of pediatric patients.
Rachel Meyers is a Consultant for Wolters Kluwer. All relevant financial relationships have been mitigated.
0.075 CEU/0.75 Hr UAN: 0107-0000-26-316-H01-P Initial release date: 9/7/2026 Expiration date: 9/7/2029 Additional CPE details can be found here.
Balancing Patient Care and Precepting Responsibilities
01 Sep 2026
00:45:54
Balancing patient care responsibilities with teaching can be challenging, particularly in busy practice environments where time and resources are limited. This course reviews practical strategies for integrating learners into daily workflow, including delegation, layered learning, and approaches for managing multiple learners. You will be better prepared to create meaningful learning experiences while maintaining efficiency, supporting learner engagement, and reducing the risk of preceptor burnout.
Host Kate Newman PharmD, Director of Experiential Education Clinical Associate Professor, Pharmacy Practice Southern Illinois University - Edwardsville
Guest Dawn Dankenbring, PharmD, BCPS Assistant Director of Experiential Education, Clinical Assistant Professor of Pharmacy Practice SIUE School of Pharmacy
Learning Objectives At the end of this course, preceptors will be able to: 1. Describe strategies for integrating learners into workflow in busy pharmacy practice settings. 2. Explain approaches to balancing patient care responsibilities with effective precepting and learner engagement.
0.075 CEU/0.75 Hr UAN: 0107-0000-26-310-H99-P Initial release date: 8/24/2026 Expiration date: 8/24/2029 Additional CPE details can be found here.
The speakers have no relevant financial relationships with ineligible companies to disclose.
The examples shared in this episode are intended to illustrate approaches to experiential learning, service development, and patient care innovation and are not endorsements of any specific service, product, or practice model. Certain examples discussed may no longer be viable, appropriate, or permissible under current regulatory requirements. Pharmacists should exercise professional judgment and ensure compliance with applicable laws, regulations, payer requirements, and evidence-based standards when evaluating or implementing patient care services.
This program has been: Approved by the Minnesota Board of Pharmacy as education for Minnesota pharmacy preceptors.
Reviewed by the Texas Consortium on Experiential Programs and has been designated as preceptor education and training for Texas preceptors.
Managing Cardiovascular-Kidney-Metabolic (CKM) Syndrome in Patient Care
31 Aug 2026
00:37:18
Cardiovascular-Kidney-Metabolic (CKM) syndrome recognizes the interconnected relationship among cardiovascular disease, kidney disease, obesity, diabetes, and other metabolic risk factors that contribute to long-term health outcomes. The first-ever CKM clinical practice guideline introduces a framework for risk assessment, staging, prevention, and management, emphasizing early identification and coordinated care across disease states. You will be better prepared to recognize CKM syndrome, understand its implications for patient care, and support evidence-based strategies to reduce cardiovascular, kidney, and metabolic risk.
GUEST Christine Schumacher, PharmD, BCPS, BCACP, BCCP, BC-ADM, CDCES, FCCP Professor, Pharmacy Practice and Clinical Pharmacist Midwestern University
GET CE FOR LISTENING! Stay Compliant. Grow Clinically. Practice with Confidence.
Pharmacist CE Subscription: All your CE in one convenient subscription. All episodes, CE, and Practice Resources for the GameChangers Clinical Update is included with your Pharmacist CE Subscription. But wait…there’s even more!
The Pharmacist CE Subscription includes: - Compliance and licensure CE - GameChangers Clinical Updates - Practical continuing education across patient care topics
*The subscription does not include microcredentials or certificates, which are available separately for pharmacists seeking specialized service training.
PRACTICE RESOURCE Receive the exclusive Practice Resource to use as a reference guide for this episode by purchasing the Pharmacist CE Subscription.
CPE REDEMPTION This course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation to claim credit:
CPE INFORMATION Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Describe the stages and key components of cardiovascular-kidney-metabolic syndrome. 2. Explain evidence-based strategies for identifying and managing patients at risk for CKM syndrome.
Christine Schumacher is a Speaker and Advisory Board Member for Abbott. All relevant financial relationships have been mitigated.
0.075 CEU/0.75 Hr UAN: 0107-0000-26-315-H01-P Initial release date: 8/31/2026 Expiration date: 8/31/2029 Additional CPE details can be found here.
The condition long known as polycystic ovary syndrome (PCOS) has been renamed polyendocrine metabolic ovarian syndrome (PMOS) to better reflect its complex endocrine, metabolic, reproductive, and mental health effects. The name change highlights a growing recognition that this condition extends far beyond ovarian findings and requires a more comprehensive approach to diagnosis, treatment, and long-term risk management. You will be better prepared to understand the rationale behind the new terminology and support patients through evidence-based management of this multifaceted condition.
GUEST Erin Raney, PharmD, BCPS Professor Midwestern University College of Pharmacy
GET CE FOR LISTENING! Stay Compliant. Grow Clinically. Practice with Confidence.
Pharmacist CE Subscription: All your CE in one convenient subscription. All episodes, CE, and Practice Resources for the GameChangers Clinical Update is included with your Pharmacist CE Subscription. But wait…there’s even more!
The Pharmacist CE Subscription includes: - Compliance and licensure CE - GameChangers Clinical Updates - Practical continuing education across patient care topics
*The subscription does not include microcredentials or certificates, which are available separately for pharmacists seeking specialized service training.
PRACTICE RESOURCE Receive the exclusive Practice Resource to use as a reference guide for this episode by purchasing the Pharmacist CE Subscription.
CPE REDEMPTION This course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation to claim credit:
CPE INFORMATION Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Describe the rationale for the transition from polycystic ovary syndrome (PCOS) to polyendocrine metabolic ovarian syndrome (PMOS). 2. Explain the endocrine, metabolic, and reproductive features that influence the management of PMOS.
Rachel Maynard and Erin Raney have no relevant financial relationships to disclose.
0.075 CEU/0.75 Hr UAN: 0107-0000-26-314-H01-P Initial release date: 8/24/2026 Expiration date: 8/24/2029 Additional CPE details can be found here.
Assessing Learner Performance With Confidence and Consistency
17 Aug 2026
00:52:43
Assessing learner performance is one of the most important and challenging responsibilities of a pharmacy preceptor. This course reviews practical strategies for evaluating clinical knowledge, communication, professionalism, and other key competencies while providing meaningful feedback that supports learner growth. You will be better prepared to assess performance consistently, navigate challenging evaluation situations, and document learner progress with confidence.
Host Kate Newman PharmD, Director of Experiential Education Clinical Associate Professor, Pharmacy Practice Southern Illinois University - Edwardsville
Guest Shane Tolleson, PharmD, PNAP Dirctor, Ambulatory Care APPEs; Clinical Assistant Professor University of Houston College of Pharmacy
Learning Objectives At the end of this course, preceptors will be able to: 1. Describe strategies for assessing learner performance across key competency areas, including clinical knowledge, communication, and professionalism. 2. Explain approaches for providing feedback and documenting learner performance in a fair, consistent, and objective manner.
0.1 CEU/1.0 Hr UAN: 0107-0000-26-309-H99-P Initial release date: 8/17/2026 Expiration date: 8/17/2029 Additional CPE details can be found here.
The speakers have no relevant financial relationships with ineligible companies to disclose.
The examples shared in this episode are intended to illustrate approaches to experiential learning, service development, and patient care innovation and are not endorsements of any specific service, product, or practice model. Certain examples discussed may no longer be viable, appropriate, or permissible under current regulatory requirements. Pharmacists should exercise professional judgment and ensure compliance with applicable laws, regulations, payer requirements, and evidence-based standards when evaluating or implementing patient care services.
This program has been: Approved by the Minnesota Board of Pharmacy as education for Minnesota pharmacy preceptors.
Reviewed by the Texas Consortium on Experiential Programs and has been designated as preceptor education and training for Texas preceptors.
Integrating Evidence-Based Functional Medicine Concepts into Pharmacy Care
17 Aug 2026
00:35:34
Interest in functional medicine and direct-to-consumer diagnostic testing continues to grow, shaping how many patients think about prevention, wellness, and chronic disease management. This course explores key concepts in functional medicine and examines how pharmacists can thoughtfully evaluate these approaches through an evidence-based lens. You will gain practical insight to support informed patient conversations while maintaining professional standards and scope-appropriate care.
GUEST Josie Ross, Pharm D PIC Phillips Family Pharmacy and Compounding
GET CE FOR LISTENING! Stay Compliant. Grow Clinically. Practice with Confidence.
Pharmacist CE Subscription: All your CE in one convenient subscription. All episodes, CE, and Practice Resources for the GameChangers Clinical Update is included with your Pharmacist CE Subscription. But wait…there’s even more!
The Pharmacist CE Subscription includes: - Compliance and licensure CE - GameChangers Clinical Updates - Practical continuing education across patient care topics
*The subscription does not include microcredentials or certificates, which are available separately for pharmacists seeking specialized service training.
PRACTICE RESOURCE Receive the exclusive Practice Resource to use as a reference guide for this episode by purchasing the Pharmacist CE Subscription.
CPE REDEMPTION This course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation to claim credit:
CPE INFORMATION Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Describe foundational principles of functional medicine and their relevance to evidence-based care in pharmacy. 2. Summarize factors pharmacists should consider when evaluating the evidence supporting functional medicine approaches.
Rachel Maynard and Josie Ross have no relevant financial relationships to disclose.
0.05 CEU/0.5 Hr UAN: 0107-0000-26-308-H01-P Initial release date: 8/17/2026 Expiration date: 8/17/2029 Additional CPE details can be found here.
Practical Tips for Managing Common Skin Conditions
10 Aug 2026
00:32:09
Skin conditions are among the most common reasons patients seek advice from healthcare professionals, creating frequent opportunities for pharmacist intervention and support. This course reviews common dermatologic conditions encountered in pharmacy practice, including eczema, poison ivy, and other minor skin conditions and infections, while exploring the pharmacist's role in screening, triage, treatment selection, patient counseling, and prevention. You will be better prepared to support evidence-based management of common skin conditions and help patients access appropriate dermatologic care.
GUEST Jamie McConaha, PharmD, BCACP, CDCES, FCCP Associate Professor of Pharmacy Practice Duquesne University School of Pharmacy
GET CE FOR LISTENING! Stay Compliant. Grow Clinically. Practice with Confidence.
Pharmacist CE Subscription: All your CE in one convenient subscription. All episodes, CE, and Practice Resources for the GameChangers Clinical Update is included with your Pharmacist CE Subscription. But wait…there’s even more!
The Pharmacist CE Subscription includes: - Compliance and licensure CE - GameChangers Clinical Updates - Practical continuing education across patient care topics
*The subscription does not include microcredentials or certificates, which are available separately for pharmacists seeking specialized service training.
PRACTICE RESOURCE Receive the exclusive Practice Resource to use as a reference guide for this episode by purchasing the Pharmacist CE Subscription.
CPE REDEMPTION This course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation to claim credit:
CPE INFORMATION Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Describe clinical features and management considerations for common skin conditions encountered in pharmacy practice.
2. Explain the pharmacist's role in screening, triage, treatment selection, patient counseling, and prevention of dermatologic conditions.
Rachel Maynard and Jamie McConaha have no relevant financial relationships to disclose.
0.05 CEU/0.5 Hr UAN: 0107-0000-26-307-H01-P Initial release date: 8/10/2026 Expiration date: 8/10/2027 Additional CPE details can be found here.
Pediatric irritable bowel syndrome with constipation (IBS-C) can significantly affect quality of life and presents unique treatment and counseling challenges for patients and families. This course reviews evolving management strategies for pediatric IBS-C, including newly approved treatment options and practical considerations for therapy selection. You will be better prepared to evaluate treatment approaches and counsel families on the safe and appropriate use of therapy for pediatric IBS-C.
GUEST Christopher Hartley, PharmD, BCPPS Pediatric Clinical Pharmacy Specialist, The Johns Hopkins Hospital
GET CE FOR LISTENING! Stay Compliant. Grow Clinically. Practice with Confidence.
Pharmacist CE Subscription: All your CE in one convenient subscription. All episodes, CE, and Practice Resources for the GameChangers Clinical Update is included with your Pharmacist CE Subscription. But wait…there’s even more!
The Pharmacist CE Subscription includes: - Compliance and licensure CE - GameChangers Clinical Updates - Practical continuing education across patient care topics
*The subscription does not include microcredentials or certificates, which are available separately for pharmacists seeking specialized service training.
PRACTICE RESOURCE Receive the exclusive Practice Resource to use as a reference guide for this episode by purchasing the Pharmacist CE Subscription.
CPE REDEMPTION This course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation to claim credit:
CPE INFORMATION Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Describe current treatment considerations for pediatric IBS-C, including recently approved pharmacologic options. 2. Compare factors that influence treatment selection and family counseling for pediatric IBS-C.
Rachel Maynard and Christopher Hartley have no relevant financial relationships to disclose.
0.075 CEU/0.75 Hr UAN: 0107-0000-26-300-H01-P Initial release date: 8/3/2026 Expiration date: 8/3/2029 Additional CPE details can be found here.
Sunscreen Updates and Skin Cancer Prevention Strategies
27 Jul 2026
00:39:52
Skin cancer remains one of the most common cancers in the United States, making effective sun protection an important component of preventive care. This course reviews sunscreen best practices, common patient questions, and recent updates affecting sunscreen products, including the addition of a new active ingredient to the OTC sunscreen monograph. You will be better prepared to provide evidence-based recommendations on sunscreen selection, sun safety, and skin cancer prevention.
GUEST Kendall Guthrie, PharmD, BCACP Director of Co-Curriculum/Clinical Professor, UMKC School of Pharmacy
GET CE FOR LISTENING! Stay Compliant. Grow Clinically. Practice with Confidence.
Pharmacist CE Subscription: All your CE in one convenient subscription. All episodes, CE, and Practice Resources for the GameChangers Clinical Update is included with your Pharmacist CE Subscription. But wait…there’s even more!
The Pharmacist CE Subscription includes: - Compliance and licensure CE - GameChangers Clinical Updates - Practical continuing education across patient care topics
*The subscription does not include microcredentials or certificates, which are available separately for pharmacists seeking specialized service training.
PRACTICE RESOURCE Receive the exclusive Practice Resource to use as a reference guide for this episode by purchasing the Pharmacist CE Subscription.
CPE REDEMPTION This course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation to claim credit:
CPE INFORMATION Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Describe current recommendations for sunscreen use and sun protection to reduce the risk of skin cancer. 2. Explain pharmacist-relevant considerations for sunscreen selection, including formulation differences, active ingredients, and patient counseling.
Rachel Maynard and [Speaker] have no relevant financial relationships to disclose.
0.075 CEU/0.75 Hr UAN: 0107-0000-26-289-H01-P Initial release date: 7/27/2026 Expiration date: 7/27/2029 Additional CPE details can be found here.
Primary open-angle glaucoma is a progressive eye disease that can lead to irreversible vision loss without timely treatment and ongoing monitoring. This course reviews practical approaches to glaucoma management, including treatment goals, common medication options, and factors that influence adherence and long-term disease control. You will be better prepared to support patients receiving glaucoma therapy through medication counseling, adherence support, and reinforcement of appropriate follow-up care.
GUEST Stephanie Conway-Allen, PharmD Associate Professor of Pharmacy Practice, Massachusetts College of Pharmacy and Health Sciences -Worcester/Manchester
GET CE FOR LISTENING! Stay Compliant. Grow Clinically. Practice with Confidence.
Pharmacist CE Subscription: All your CE in one convenient subscription. All episodes, CE, and Practice Resources for the GameChangers Clinical Update is included with your Pharmacist CE Subscription. But wait…there’s even more!
The Pharmacist CE Subscription includes: - Compliance and licensure CE - GameChangers Clinical Updates - Practical continuing education across patient care topics
*The subscription does not include microcredentials or certificates, which are available separately for pharmacists seeking specialized service training.
PRACTICE RESOURCE Receive the exclusive Practice Resource to use as a reference guide for this episode by purchasing the Pharmacist CE Subscription.
CPE REDEMPTION This course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation to claim credit:
CPE INFORMATION Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Describe treatment goals and common management strategies for primary open-angle glaucoma. 2. Explain pharmacist-relevant considerations for counseling and supporting patients receiving glaucoma therapy.
Rachel Maynard and Stephanie Conway-Allen have no relevant financial relationships to disclose.
0.075 CEU/0.75 Hr UAN: 0107-0000-26-252-H01-P Initial release date: 7/20/2026 Expiration date: 7/20/2029 Additional CPE details can be found here.
International travel exposes patients to a range of infectious disease risks, making pre-travel planning and vaccination an important part of patient care. This course reviews recent travel health updates, including vaccine recommendations, emerging safety considerations, and prevention strategies for common travel-related illnesses. You will be better prepared to provide evidence-based recommendations, assess patient risk, and counsel travelers on vaccines and preventive measures before international travel.
GUEST Lana Saad Sherr, PharmD Assistant Dean for Professional Affairs, University of Maryland Eastern Shore
GET CE FOR LISTENING! Stay Compliant. Grow Clinically. Practice with Confidence.
Pharmacist CE Subscription: All your CE in one convenient subscription. All episodes, CE, and Practice Resources for the GameChangers Clinical Update is included with your Pharmacist CE Subscription. But wait…there’s even more!
The Pharmacist CE Subscription includes: - Compliance and licensure CE - GameChangers Clinical Updates - Practical continuing education across patient care topics
*The subscription does not include microcredentials or certificates, which are available separately for pharmacists seeking specialized service training.
PRACTICE RESOURCE Receive the exclusive Practice Resource to use as a reference guide for this episode by purchasing the Pharmacist CE Subscription.
CPE REDEMPTION This course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation to claim credit:
CPE INFORMATION Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1.Describe key vaccine recommendations and safety considerations for patients traveling internationally. 2. Describe prevention strategies for common travel-related infectious diseases, including mosquito-borne illnesses.
Rachel Maynard and Lana Sherr have no relevant financial relationships to disclose.
0.05 CEU/0.5 Hr UAN: 0107-0000-26-251-H01-P Initial release date: 7/13/2026 Expiration date: 7/13/2027 Additional CPE details can be found here.
Deprescribing is an important component of patient care as medication regimens are reassessed to ensure ongoing appropriateness, safety, and alignment with patient goals. This course reviews key deprescribing principles, including when it may be appropriate to discontinue therapy and important considerations for patient monitoring and follow-up. You will be better prepared to support evidence-based deprescribing decisions and collaborate with patients and providers to optimize medication use.
GUEST Kristin S. Meyer, PharmD, BCGP, FASCP Professor of Pharmacy Practice, Drake University College of Pharmacy and Health Sciences
GET CE FOR LISTENING! Stay Compliant. Grow Clinically. Practice with Confidence.
Pharmacist CE Subscription: All your CE in one convenient subscription. All episodes, CE, and Practice Resources for the GameChangers Clinical Update is included with your Pharmacist CE Subscription. But wait…there’s even more!
The Pharmacist CE Subscription includes: - Compliance and licensure CE - GameChangers Clinical Updates - Practical continuing education across patient care topics
*The subscription does not include microcredentials or certificates, which are available separately for pharmacists seeking specialized service training.
PRACTICE RESOURCE Receive the exclusive Practice Resource to use as a reference guide for this episode by purchasing the Pharmacist CE Subscription.
CPE REDEMPTION This course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation to claim credit:
CPE INFORMATION Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Discuss key principles and clinical considerations for deprescribing. 2. Compare patient-specific factors that influence evidence-based deprescribing decisions, including risks, benefits, and treatment goals.
Rachel Maynard and Kristin Meyer have no relevant financial relationships to disclose.
0.075 CEU/0.75 Hr UAN: 0107-0000-26-249-H01-P Initial release date: 7/6/2026 Expiration date: 7/6/2029 Additional CPE details can be found here.
Rethinking the Use of Beta-Blockers After a Myocardial Infarction
29 Jun 2026
00:47:56
Beta-blockers have long been considered a foundational therapy following myocardial infarction, yet emerging data are challenging their routine use in all patients. This course discusses recent evidence on outcomes associated with beta-blocker therapy after MI, particularly in patients without reduced ejection fraction, and explores the ongoing debate over the benefits, risks, and duration of therapy. You will gain practical insight to support evidence-based decision-making and individualized pharmacotherapy recommendations in post-MI care.
GUESTS Anna Crider, PharmD, BCCP Clinical Pharmacy Specialist, Emory University Hospital
Taylor Merritt, PharmD PGY2 Internal Medicine Pharmacy Resident, Chief Pharmacy Resident, Emory University Hospital
GET CE FOR LISTENING! Stay Compliant. Grow Clinically. Practice with Confidence.
Pharmacist CE Subscription: All your CE in one convenient subscription. All episodes, CE, and Practice Resources for the GameChangers Clinical Update is included with your Pharmacist CE Subscription. But wait…there’s even more!
The Pharmacist CE Subscription includes: - Compliance and licensure CE - GameChangers Clinical Updates - Practical continuing education across patient care topics
*The subscription does not include microcredentials or certificates, which are available separately for pharmacists seeking specialized service training.
PRACTICE RESOURCE Receive the exclusive Practice Resource to use as a reference guide for this episode by purchasing the Pharmacist CE Subscription.
CPE REDEMPTION This course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation to claim credit:
CPE INFORMATION Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Summarize contemporary evidence regarding beta-blocker therapy after myocardial infarction. 2. Describe clinical considerations that may influence the decision to initiate, continue, or deprescribe beta-blocker therapy following myocardial infarction.
Rachel Maynard, Anna Crider, and Taylor Merritt have no relevant financial relationships to disclose.
0.075 CEU/0.75 Hr UAN: 0107-0000-26-242-H01-P Initial release date: 6/29/2026 Expiration date: 6/29/2027 Additional CPE details can be found here.
Sexually transmitted infection (STI) management continues to evolve, with new treatment options, prevention strategies, and practice considerations that are important for pharmacists to understand. This course reviews recent updates in STI care, including newly approved oral therapies for gonorrhea and doxycycline post-exposure prophylaxis. You will be better prepared to recognize practice-relevant changes and support evidence-based STI prevention, treatment, and patient counseling.
GUEST Francisco Franco, PharmD, MS, AAHIVP Registered Store Manager, Walgreens
GET CE FOR LISTENING! Stay Compliant. Grow Clinically. Practice with Confidence.
Pharmacist CE Subscription: All your CE in one convenient subscription. All episodes, CE, and Practice Resources for the GameChangers Clinical Update is included with your Pharmacist CE Subscription. But wait…there’s even more!
The Pharmacist CE Subscription includes: - Compliance and licensure CE - GameChangers Clinical Updates - Practical continuing education across patient care topics
*The subscription does not include microcredentials or certificates, which are available separately for pharmacists seeking specialized service training.
PRACTICE RESOURCE Receive the exclusive Practice Resource to use as a reference guide for this episode by purchasing the Pharmacist CE Subscription.
CPE REDEMPTION This course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation to claim credit:
CPE INFORMATION Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Describe recent updates in STI treatment and prevention that are relevant to pharmacy practice. 2. Compare emerging strategies for managing gonorrhea and STI post-exposure prophylaxis.
Rachel Maynard and Francisco Franco have no relevant financial relationships to disclose.
0.075 CEU/0.75 Hr UAN: 0107-0000-26-241-H01-P Initial release date: 6/22/2026 Expiration date: 6/22/2027 Additional CPE details can be found here.
Precept2Practice: Designing High-Impact Rotation Experiences for Pharmacy Learners
17 Jun 2026
00:58:10
Well-designed rotation experiences are essential to developing competent and confident student pharmacists and residents. This course discusses how to structure rotations, align with institutional expectations, and create meaningful schedules, activities, and deliverables that balance service and learning, while introducing principles of deliberate practice to support ongoing skill development. You will gain practical strategies for designing engaging, well-organized, high-impact experiential learning experiences
Host Kate Newman PharmD, Director of Experiential Education Clinical Associate Professor, Pharmacy Practice Southern Illinois University - Edwardsville
Guest Mayank Amin, PharmD, RPH, MBA Pharmacist Owner, Skippack Pharmacy
Learning Objectives At the end of this course, preceptors will be able to: 1. Describe key elements of effective rotation design, including structure, expectations, and learning activities. 2. Identify strategies to create engaging and high-impact rotation experiences for pharmacy learners.
0.1 CEU/1.0 Hr UAN: 0107-0000-26-246-H99-P Initial release date: 6/17/2026 Expiration date: 6/17/2029 Additional CPE details can be found here.
The speakers have no relevant financial relationships with ineligible companies to disclose.
The examples shared in this episode are intended to illustrate approaches to experiential learning, service development, and patient care innovation and are not endorsements of any specific service, product, or practice model. Certain examples discussed may no longer be viable, appropriate, or permissible under current regulatory requirements. Pharmacists should exercise professional judgment and ensure compliance with applicable laws, regulations, payer requirements, and evidence-based standards when evaluating or implementing patient care services.
This program has been: Approved by the Minnesota Board of Pharmacy as education for Minnesota pharmacy preceptors.
Reviewed by the Texas Consortium on Experiential Programs and has been designated as preceptor education and training for Texas preceptors.
Interest in peptide therapies has grown rapidly, with increasing patient questions driven by social media, wellness trends, and evolving access through compounding and online sources. This course reviews what peptides are, the current state of evidence supporting their use, and key safety and regulatory considerations relevant to patient care. You will be better prepared to apply an evidence-based approach when discussing peptides, including evaluating risks, addressing misconceptions, and guiding patients toward safe and informed decisions.
GET CE FOR LISTENING! Stay Compliant. Grow Clinically. Practice with Confidence.
Pharmacist CE Subscription: All your CE in one convenient subscription. All episodes, CE, and Practice Resources for the GameChangers Clinical Update is included with your Pharmacist CE Subscription. But wait…there’s even more!
The Pharmacist CE Subscription includes: - Compliance and licensure CE - GameChangers Clinical Updates - Practical continuing education across patient care topics
*The subscription does not include microcredentials or certificates, which are available separately for pharmacists seeking specialized service training.
PRACTICE RESOURCE Receive the exclusive Practice Resource to use as a reference guide for this episode by purchasing the Pharmacist CE Subscription.
CPE REDEMPTION This course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation to claim credit:
CPE INFORMATION Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Describe the role of peptides in human physiology and the current evidence supporting their therapeutic use. 2. Identify safety, regulatory, and patient-specific considerations relevant to the use of peptides in clinical practice.
Rachel Maynard and Nicolette Mathey have no relevant financial relationships to disclose.
0.1 CEU/1.0 Hr UAN: 0107-0000-26-240-H01-P Initial release date: 6/15/2026 Expiration date: 6/15/2027 Additional CPE details can be found here.
Antibiotics are frequently prescribed in dental care, yet evidence suggests they are often unnecessary and can expose patients to significant risks, including Clostridioides difficile infection. This course reviews appropriate antibiotic use in dental settings, including indications, preferred treatment options, and safety concerns associated with specific agents. You will be better prepared to support evidence-based antibiotic use, identify opportunities for intervention, and collaborate with dental colleagues to promote antimicrobial stewardship.
GET CE FOR LISTENING! Stay Compliant. Grow Clinically. Practice with Confidence.
Pharmacist CE Subscription: All your CE in one convenient subscription. All episodes, CE, and Practice Resources for the GameChangers Clinical Update is included with your Pharmacist CE Subscription. But wait…there’s even more!
The Pharmacist CE Subscription includes: - Compliance and licensure CE - GameChangers Clinical Updates - Practical continuing education across patient care topics
*The subscription does not include microcredentials or certificates, which are available separately for pharmacists seeking specialized service training.
PRACTICE RESOURCE Receive the exclusive Practice Resource to use as a reference guide for this episode by purchasing the Pharmacist CE Subscription.
CPE REDEMPTION This course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation to claim credit:
CPE INFORMATION Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Describe appropriate indications for antibiotic use in common dental conditions. 2. Compare antibiotic options used in dental care, including safety considerations and risks associated with specific agents.
Rachel Maynard and Julie Goldberg have no relevant financial relationships to disclose.
0.075 CEU/0.75 Hr UAN: 0107-0000-26-224-H01-P Initial release date: 6/8/2026 Expiration date: 6/8/2027 Additional CPE details can be found here.
Chronic pain is a prevalent and complex condition where evidence continues to evolve around commonly prescribed therapies. This course discusses the latest systematic review comparing tramadol with placebo in adults with chronic pain, highlighting limited analgesic benefits and the balance of potential harms versus benefits that pharmacists should understand. You will gain evidence-based insights to guide medication review, patient counseling, and clinical decision-making in chronic pain management.
GUEST Emma Murter, PharmD, MPH Clinical Pharmacist, Intermountain Health
GET CE FOR LISTENING! Stay Compliant. Grow Clinically. Practice with Confidence.
Pharmacist CE Subscription: All your CE in one convenient subscription. All episodes, CE, and Practice Resources for the GameChangers Clinical Update is included with your Pharmacist CE Subscription. But wait…there’s even more!
The Pharmacist CE Subscription includes: - Compliance and licensure CE - GameChangers Clinical Updates - Practical continuing education across patient care topics
*The subscription does not include microcredentials or certificates, which are available separately for pharmacists seeking specialized service training.
PRACTICE RESOURCE Receive the exclusive Practice Resource to use as a reference guide for this episode by purchasing the Pharmacist CE Subscription.
CPE REDEMPTION This course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation to claim credit:
CPE INFORMATION Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Summarize the current evidence on tramadol’s efficacy and safety profile in chronic pain based on placebo-controlled randomized trials. 2. Describe the clinical implications of recent tramadol evidence for pharmacist-led medication management in chronic pain care.
Rachel Maynard and Emma Murter have no relevant financial relationships to disclose.
0.05 CEU/0.5 Hr UAN: 0107-0000-26-223-H01-P Initial release date: 6/1/2026 Expiration date: 6/1/2027 Additional CPE details can be found here.
Safe and Informed Use of Melatonin in Pediatric Patients
25 May 2026
00:37:16
Melatonin—widely available over the counter and often perceived as “natural and safe”—has become increasingly used by caregivers to address sleep disturbances in children and adolescents, yet its proper role and safety profile in pediatrics remain nuanced and evolving. This course examines current evidence on indications such as insomnia and circadian rhythm sleep disorders, highlights concerns about unregulated supplement use and adverse effects, and reviews practical considerations for safe and informed use in pediatric patients. You will gain insight into how to support caregivers with balanced counseling, emphasize behavioral and environmental strategies, and apply clinical judgment when melatonin is being considered for sleep management in pediatric patients.
GUEST Monica Bogenschutz, PharmD, BCPS, BCPPS, DPLA, FPPA Pediatric Clinical Pharmacist and PGY2 Pediatric Pharmacy Residency Program Director at UW Health
GET CE FOR LISTENING! Stay Compliant. Grow Clinically. Practice with Confidence.
Pharmacist CE Subscription: All your CE in one convenient subscription. All episodes, CE, and Practice Resources for the GameChangers Clinical Update is included with your Pharmacist CE Subscription. But wait…there’s even more!
The Pharmacist CE Subscription includes: - Compliance and licensure CE - GameChangers Clinical Updates - Practical continuing education across patient care topics
*The subscription does not include microcredentials or certificates, which are available separately for pharmacists seeking specialized service training.
PRACTICE RESOURCE Receive the exclusive Practice Resource to use as a reference guide for this episode by purchasing the Pharmacist CE Subscription.
CPE REDEMPTION This course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation to claim credit:
CPE INFORMATION Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Describe common pediatric indications and available evidence for melatonin use in children and adolescents
2. Identify pharmacist considerations related to safety, dosing, behavioral counseling, and monitoring when melatonin is recommended or used in pediatric patients.
Rachel Maynard and Monica Bogenschutz have no relevant financial relationships to disclose.
0.075 CEU/0.75 Hr UAN: 0107-0000-26-222-H01-P Initial release date: 5/25/2026 Expiration date: 5/25/2027 Additional CPE details can be found here.
A Review of Acute Rescue Therapies in Clinical Practice
18 May 2026
00:32:09
Acute rescue medications are critical in time-sensitive emergencies, and pharmacists play an essential role in ensuring patients and caregivers are prepared to use them correctly. This course discusses the roles of glucagon, naloxone, and epinephrine, including recent updates on novel formulations and device innovations that are reshaping emergency response in community settings. You will gain practical insights to strengthen counseling, improve readiness, and support optimal outcomes when seconds matter most.
GUEST Wendy Mobley-Bukstein, PharmD, BCACP, CDCES, CHWC, NASM-CPT Professor of Pharmacy Practice Drake University CPHS
GET CE FOR LISTENING! Stay Compliant. Grow Clinically. Practice with Confidence.
Pharmacist CE Subscription: All your CE in one convenient subscription. All episodes, CE, and Practice Resources for the GameChangers Clinical Update is included with your Pharmacist CE Subscription. But wait…there’s even more!
The Pharmacist CE Subscription includes: - Compliance and licensure CE - GameChangers Clinical Updates - Practical continuing education across patient care topics
*The subscription does not include microcredentials or certificates, which are available separately for pharmacists seeking specialized service training.
PRACTICE RESOURCE Receive the exclusive Practice Resource to use as a reference guide for this episode by purchasing the Pharmacist CE Subscription.
CPE REDEMPTION This course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation to claim credit:
CPE INFORMATION Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Describe the mechanisms of action and primary indications for glucagon, naloxone, and epinephrine as acute rescue medications. 2. Summarize recent updates for glucagon, naloxone, and epinephrine that impact pharmacist counseling and patient access.
Rachel Maynard has no relevant financial relationships with ineligible companies to disclose.
Wendy Mobley-Bukstein is a Diabetes Care Speaker for Abbott. All relevant financial relationships have been mitigated.
0.05 CEU/0.5 Hr UAN: 0107-0000-26-131-H01-P Initial release date: 5/18/2026 Expiration date: 5/18/2027 Additional CPE details can be found here.
MOUD Prescribing Authority and Practice Implications
11 May 2026
00:50:50
Access to medications for opioid use disorder (MOUD) remains a critical component of addressing the ongoing opioid crisis, and recent federal authorization now allows pharmacists to independently prescribe buprenorphine following appropriate training. This course reviews the regulatory changes, outlines clinical and operational considerations for pharmacist-led MOUD prescribing, and discusses the opportunities and responsibilities that accompany expanded prescriptive authority. You will gain practical insight into how integrating MOUD prescribing into pharmacy practice can improve treatment access while maintaining safe, evidence-based care.
HOST Rachel Maynard, PharmD GameChangers Podcast Host and Clinical Editor, CEimpact Lead Editor, Pyrls
GUEST Korey Kreider, PharmD Pharmacist Owner Medicine Man
GET CE FOR LISTENING! Stay Compliant. Grow Clinically. Practice with Confidence.
Pharmacist CE Subscription: All your CE in one convenient subscription. All episodes, CE, and Practice Resources for the GameChangers Clinical Update is included with your Pharmacist CE Subscription. But wait…there’s even more!
The Pharmacist CE Subscription includes: - Compliance and licensure CE - GameChangers Clinical Updates - Practical continuing education across patient care topics
*The subscription does not include microcredentials or certificates, which are available separately for pharmacists seeking specialized service training.
PRACTICE RESOURCE Receive the exclusive Practice Resource to use as a reference guide for this episode by purchasing the GameChangers Clinical Update Series.
CPE REDEMPTION This course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation to claim credit:
CPE INFORMATION Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Describe recent federal policy changes authorizing pharmacists to independently prescribe buprenorphine for opioid use disorder. 2. Identify clinical, regulatory, and workflow considerations associated with integrating MOUD prescribing into pharmacy practice.
Rachel Maynard and Korey Kreider have no relevant financial relationships with ineligible companies to disclose.
0.1 CEU/1.0 Hr UAN: 0107-0000-26-150-H01-P Initial release date: 5/11/2026 Expiration date: 5/11/2027 Additional CPE details can be found here.
Practical Updates From the New Cholesterol Guidelines
04 May 2026
00:41:12
Updated cholesterol guidelines introduce important changes in cardiovascular risk assessment and lipid management that directly impact pharmacist practice. This course reviews key updates from the new ACC/AHA dyslipidemia guideline, including risk assessment tools, LDL-C targets, and evolving roles for statin and nonstatin therapies. You will be better prepared to identify practice-relevant recommendations and support evidence-based lipid management in patient care.
HOST Rachel Maynard, PharmD GameChangers Podcast Host and Clinical Editor, CEimpact Lead Editor, Pyrls
Janelle Ruisinger, PharmD, FAPhA Associate Dean for Academic Affairs and Clinical Professor The University of Kansas School of Pharmacy
GET CE FOR LISTENING! Stay Compliant. Grow Clinically. Practice with Confidence.
Pharmacist CE Subscription: All your CE in one convenient subscription. All episodes, CE, and Practice Resources for the GameChangers Clinical Update is included with your Pharmacist CE Subscription. But wait…there’s even more!
The Pharmacist CE Subscription includes: - Compliance and licensure CE - GameChangers Clinical Updates - Practical continuing education across patient care topics
*The subscription does not include microcredentials or certificates, which are available separately for pharmacists seeking specialized service training.
PRACTICE RESOURCE Receive the exclusive Practice Resource to use as a reference guide for this episode by purchasing the Pharmacist CE Subscription.
CPE REDEMPTION This course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation to claim credit:
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Describe key pharmacist-relevant updates in the new ACC/AHA Guideline for the Management of Dyslipidemia.
2. Differentiate risk assessment and lipid-lowering treatment considerations that may influence pharmacist recommendations under the updated guideline.
Rachel Maynard and Janelle Ruisinger have no relevant financial relationships to disclose.
0.75 CEU/0.75 Hr UAN: 0107-0000-26-156-H01-P Initial release date: 5/4/2026 Expiration date: 5/4/2027 Additional CPE details can be found here.
Seasonal allergies affect millions of patients each year and are a common reason individuals seek guidance from pharmacists for symptom relief and product selection. This course reviews the pathophysiology, common symptoms, and current management strategies for seasonal allergies, with a focus on over-the-counter treatment options and patient counseling considerations. You will strengthen your ability to recommend evidence-based therapies, differentiate treatment options, and support patients in managing seasonal allergy symptoms effectively.
HOST Rachel Maynard, PharmD GameChangers Podcast Host and Clinical Editor, CEimpact Lead Editor, Pyrls
Tyler Kiles, PharmD, MPH, BC-ADM Clinical Associate Professor The University of Texas at Austin College of Pharmacy
GET CE FOR LISTENING! Stay Compliant. Grow Clinically. Practice with Confidence.
Pharmacist CE Subscription: All your CE in one convenient subscription. All episodes, CE, and Practice Resources for the GameChangers Clinical Update is included with your Pharmacist CE Subscription. But wait…there’s even more!
The Pharmacist CE Subscription includes: - Compliance and licensure CE - GameChangers Clinical Updates - Practical continuing education across patient care topics
*The subscription does not include microcredentials or certificates, which are available separately for pharmacists seeking specialized service training.
PRACTICE RESOURCE Receive the exclusive Practice Resource to use as a reference guide for this episode by purchasing the Pharmacist CE Subscription.
CPE REDEMPTION This course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation to claim credit:
CPE INFORMATION Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Describe the pathophysiology, common symptoms, and underlying causes of seasonal allergic rhinitis.
2. Compare pharmacologic and nonpharmacologic treatment options for seasonal allergies, including considerations for safe and effective use in patient care.
Rachel Maynard and Tyler Kiles have no relevant financial relationships to disclose.
0.05 CEU/0.5 Hr UAN: 0107-0000-26-155-H01-P Initial release date: 4/27/2026 Expiration date: 4/27/2027 Additional CPE details can be found here.
Federal guidelines now recognize self‑collected HPV testing as an option for cervical cancer screening for average‑risk individuals, offering a more accessible and patient‑preferred alternative to clinician‑collected samples. This course explains current guideline updates supporting self‑collection, highlights screening intervals and follow‑up recommendations, and explores how pharmacists can support patients in choosing appropriate screening options and navigating coverage and reimbursement. You will learn practical strategies to educate patients, help them understand test options and results, and integrate HPV self‑screening into preventive health services in your practice.
HOST Rachel Maynard, PharmD GameChangers Podcast Host and Clinical Editor, CEimpact Lead Editor, Pyrls
GUEST Sarah Westberg, PharmD, FCCP, BCPS Professor & Associate Dean for Professional Affairs University of Minnesota College of Pharmacy
GET CE FOR LISTENING! Stay Compliant. Grow Clinically. Practice with Confidence.
Pharmacist CE Subscription: All your CE in one convenient subscription. All episodes, CE, and Practice Resources for the GameChangers Clinical Update is included with your Pharmacist CE Subscription. But wait…there’s even more!
The Pharmacist CE Subscription includes: - Compliance and licensure CE - GameChangers Clinical Updates - Practical continuing education across patient care topics
*The subscription does not include microcredentials or certificates, which are available separately for pharmacists seeking specialized service training.
PRACTICE RESOURCE Receive the exclusive Practice Resource to use as a reference guide for this episode by purchasing the Pharmacist CE Subscription.
CPE REDEMPTION This course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation to claim credit:
CPE INFORMATION Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Describe recent guideline updates supporting self‑collected HPV testing as part of cervical cancer screening.
2. Identify pharmacist‑led strategies to counsel patients on self‑screening options, appropriate follow‑up steps, and considerations related to insurance coverage and reimbursement.
Rachel Maynard and Sarah Westberg have no relevant financial relationships to disclose.
0.05 CEU/0.5 Hr UAN: 0107-0000-26-075-H01-P Initial release date: 4/20/2026 Expiration date: 4/20/2027 Additional CPE details can be found
Treatment for atopic dermatitis has changed dramatically, with new therapies offering more targeted relief across the severity spectrum. This course highlights recent drug approvals, updated guideline recommendations, and the clinical implications of managing atopic dermatitis as a chronic inflammatory condition. You will learn how pharmacists can guide therapy decisions, enhance adherence, and improve patient outcomes in personalized atopic dermatitis care.
HOST Rachel Maynard, PharmD GameChangers Podcast Host and Clinical Editor, CEimpact Lead Editor, Pyrls
Melanie Plotke, PharmD Manager, Clinical Research American Academy of Dermatology
GET CE FOR LISTENING! Stay Compliant. Grow Clinically. Practice with Confidence.
Pharmacist CE Subscription: All your CE in one convenient subscription. All episodes, CE, and Practice Resources for the GameChangers Clinical Update is included with your Pharmacist CE Subscription. But wait…there’s even more!
The Pharmacist CE Subscription includes: - Compliance and licensure CE - GameChangers Clinical Updates - Practical continuing education across patient care topics
*The subscription does not include microcredentials or certificates, which are available separately for pharmacists seeking specialized service training.
PRACTICE RESOURCE Receive the exclusive Practice Resource to use as a reference guide for this episode by purchasing the Pharmacist CE Subscription.
CPE REDEMPTION This course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation to claim credit:
CPE INFORMATION Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Describe the updated treatment landscape for atopic dermatitis, including new topical and systemic options. 2. Identify opportunities for pharmacists to collaborate and support atopic dermatitis management through therapy recommendations, patient education, and adherence strategies.
Rachel Maynard and Melanie Plotke have no relevant financial relationships to disclose.
0.05 CEU/0.5 Hr UAN: 0107-0000-26-074-H01-P Initial release date: 4/16/2026 Expiration date: 4/16/2027 Additional CPE details can be found here.
Advancements in hypertension management are shifting the landscape of treatment, from new guideline recommendations to technological innovations. This course explores key highlights from the AHA's recent scientific statements, including single-pill combination therapy and the clinical limitations of some blood pressure devices, alongside updates to the 2025 hypertension guidelines. You will gain a clear understanding of how these changes affect patient care, medication strategies, and pharmacist-driven interventions.
Recent ACC/AHA Cholesterol Guidelines further emphasize comprehensive cardiovascular risk assessment and evidence-based management of dyslipidemia alongside other major risk factors such as hypertension. These updates complement the hypertension topics discussed in this episode by reinforcing the importance of coordinated, risk-based approaches to reducing cardiovascular disease.
This resource provides a concise, guideline-based overview of hypertension management, summarizing the 2025 ACC/AHA recommendations for blood pressure classification, treatment goals, and stepwise pharmacotherapy. It highlights first- and second-line antihypertensive options, emphasizes individualized, risk-based treatment decisions, and outlines practical considerations for therapy initiation, intensification, and monitoring to optimize cardiovascular outcomes.
HOST Rachel Maynard, PharmD GameChangers Podcast Host and Clinical Editor, CEimpact Lead Editor, Pyrls
GUEST Tomasz Jurga, PharmD, BCPS, BCACP, BCCP, HF-Cert, CDCES, AACC Clinical Pharmacist Practitioner LTC Charles S. Kettles VA Medical Center
GET CE FOR LISTENING! Stay Compliant. Grow Clinically. Practice with Confidence.
Pharmacist CE Subscription: All your CE in one convenient subscription. All episodes, CE, and Practice Resources for the GameChangers Clinical Update is included with your Pharmacist CE Subscription. But wait…there’s even more!
The Pharmacist CE Subscription includes: - Compliance and licensure CE - GameChangers Clinical Updates - Practical continuing education across patient care topics
*The subscription does not include microcredentials or certificates, which are available separately for pharmacists seeking specialized service training.
PRACTICE RESOURCE Receive the exclusive Practice Resource to use as a reference guide for this episode by purchasing the Pharmacist CE Subscription.
CPE REDEMPTION This course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation to claim credit:
Alpha-gal syndrome (AGS), a growing allergy linked to tick bites and mammalian meat exposure, is a condition pharmacists can’t afford to overlook. This course discusses the pathophysiology of the syndrome, common triggers, and emerging case trends—while highlighting how pharmacists can play a critical role in helping patients navigate safe OTC and prescription therapies by screening for allergenic excipients. You will gain practical knowledge to support patient education, ensure safe medication use, and guide appropriate referrals.
HOST Rachel Maynard, PharmD GameChangers Podcast Host and Clinical Editor, CEimpact Lead Editor, Pyrls
GUEST Geoff Wall, PharmD, BCPS Professor of Pharmacy Practice Drake University
GET CE FOR LISTENING! Stay Compliant. Grow Clinically. Practice with Confidence.
Pharmacist CE Subscription: All your CE in one convenient subscription. All episodes, CE, and Practice Resources for the GameChangers Clinical Update is included with your Pharmacist CE Subscription. But wait…there’s even more!
The Pharmacist CE Subscription includes: - Compliance and licensure CE - GameChangers Clinical Updates - Practical continuing education across patient care topics
*The subscription does not include microcredentials or certificates, which are available separately for pharmacists seeking specialized service training.
PRACTICE RESOURCE Receive the exclusive Practice Resource to use as a reference guide for this episode by purchasing the Pharmacist CE Subscription.
CPE REDEMPTION This course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation to claim credit:
CPE INFORMATION Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Describe the pathophysiology, triggers, and clinical presentation of alpha‑gal syndrome. 2. Identify pharmacist‑led strategies for patient counseling, medication review, and referral when AGS is suspected or confirmed.
Rachel Maynard and Geoff Wall have no relevant financial relationships with ineligible companies to disclose.
0.05 CEU/0.5 Hr UAN: 0107-0000-26-058-H01-P Initial release date: 3/30/2026 Expiration date: 3/30/2027 Additional CPE details can be found here.
Artificial intelligence (AI) is rapidly transforming the healthcare landscape—and pharmacy is no exception. This course explores emerging and potential uses of AI in pharmacy practice, including workflow automation, drug information access, and tools that support patient care and clinical decision-making. You will gain insight into practical considerations, limitations, and ethical responsibilities pharmacists must navigate as AI becomes more integrated into practice.
HOST Rachel Maynard, PharmD GameChangers Podcast Host and Clinical Editor, CEimpact Lead Editor, Pyrls
GUEST Timothy Aungst, PharmD Professor of Pharmacy Practice Massachusetts College of Pharmacy and Health Sciences
GET CE FOR LISTENING! Stay Compliant. Grow Clinically. Practice with Confidence.
Pharmacist CE Subscription: All your CE in one convenient subscription. All episodes, CE, and Practice Resources for the GameChangers Clinical Update is included with your Pharmacist CE Subscription. But wait…there’s even more!
The Pharmacist CE Subscription includes: - Compliance and licensure CE - GameChangers Clinical Updates - Practical continuing education across patient care topics
*The subscription does not include microcredentials or certificates, which are available separately for pharmacists seeking specialized service training.
PRACTICE RESOURCE Receive the exclusive Practice Resource to use as a reference guide for this episode by purchasing the Pharmacist CE Subscription.
CPE REDEMPTION This course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation to claim credit:
CPE INFORMATION Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Identify current and potential uses of AI that support pharmacist-led patient care services. 2. Describe considerations, limitations, and ethical concerns related to implementing AI tools in pharmacy practice.
Rachel Maynard and Timothy Aungst have no relevant financial relationships with ineligible companies to disclose.
0.05 CEU/0.5 Hr UAN: 0107-0000-26-060-H04-P Initial release date: 3/23/2026 Expiration date: 3/23/2027 Additional CPE details can be found here.
Second-Generation Antipsychotics as Adjunctive Therapy for Depression
16 Mar 2026
00:34:24
Second-generation (also known as atypical) antipsychotics are increasingly used as adjunctive therapy for patients with major depressive disorder who have an inadequate or partial response to antidepressants. This course reviews the clinical rationale for their use, highlights newly approved options, and examines key safety, efficacy, and monitoring considerations. You will gain practical guidance to support patient selection, counseling, and shared decision-making when these agents are incorporated into depression management.
HOST Rachel Maynard, PharmD GameChangers Podcast Host and Clinical Editor, CEimpact Lead Editor, Pyrls
GUEST Sarah Grady, PharmD, BCPS, BCPP Professor of Pharmacy Practice, Clinical Pharmacist Drake University/Broadlawns Medical Center
GET CE FOR LISTENING! Stay Compliant. Grow Clinically. Practice with Confidence.
Pharmacist CE Subscription: All your CE in one convenient subscription. All episodes, CE, and Practice Resources for the GameChangers Clinical Update is included with your Pharmacist CE Subscription. But wait…there’s even more!
The Pharmacist CE Subscription includes: - Compliance and licensure CE - GameChangers Clinical Updates - Practical continuing education across patient care topics
*The subscription does not include microcredentials or certificates, which are available separately for pharmacists seeking specialized service training.
PRACTICE RESOURCE Receive the exclusive Practice Resource to use as a reference guide for this episode by purchasing the Pharmacist CE Subscription.
CPE REDEMPTION This course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation to claim credit:
CPE INFORMATION Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Explain the role of second-generation (atypical) antipsychotics as adjunctive therapy in the management of major depressive disorder. 2. Identify pharmacist-relevant considerations for counseling, monitoring, and risk benefit assessment when second-generation antipsychotics are used for depression.
Rachel Maynard and Sarah Grady have no relevant financial relationships to disclose.
0.05 CEU/0.5 Hr UAN: 0107-0000-26-059-H01-P Initial release date: 3/16/2026 Expiration date: 3/16/2027 Additional CPE details can be found here.
GLP‑1 receptor agonists continue to generate clinical and media buzz, with new formulations, new approvals, and expanding areas of research. This course explores key updates, including the FDA approval of the first oral GLP‑1 for chronic weight management and ongoing investigations into GLP‑1 therapies for conditions beyond diabetes and obesity. You will gain a timely overview of recent developments in GLP‑1s and how pharmacists can anticipate and support their evolving role in patient care.
HOST Rachel Maynard, PharmD GameChangers Podcast Host and Clinical Editor, CEimpact Lead Editor, Pyrls
GUEST Christine Schumacher, PharmD, BCPS, BCACP, BCCP, BC-ADM, CDCES, FCCP Professor, Pharmacy Practice and Clinical Pharmacist Midwestern University
GET CE FOR LISTENING! Stay Compliant. Grow Clinically. Practice with Confidence.
Pharmacist CE Subscription: All your CE in one convenient subscription. All episodes, CE, and Practice Resources for the GameChangers Clinical Update is included with your Pharmacist CE Subscription. But wait…there’s even more!
The Pharmacist CE Subscription includes: - Compliance and licensure CE - GameChangers Clinical Updates - Practical continuing education across patient care topics
*The subscription does not include microcredentials or certificates, which are available separately for pharmacists seeking specialized service training.
PRACTICE RESOURCE Receive the exclusive Practice Resource to use as a reference guide for this episode by purchasing the Pharmacist CE Subscription.
CPE REDEMPTION This course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation to claim credit:
CPE INFORMATION Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Summarize recent regulatory and clinical updates related to GLP‑1 receptor agonists, including new formulations. 2. Describe emerging areas of research into the use of GLP‑1 therapies beyond diabetes and obesity treatment.
Rachel Maynard has no relevant financial relationships with ineligible companies to disclose.
Christie Schumacher is a speaker for and is on the advisory board for Abbott. All relevant financial relationships have been mitigated.
0.1 CEU/1.0 Hr UAN: 0107-0000-26-081-H01-P Initial release date: 3/9/2026 Expiration date: 3/9/2027 Additional CPE details can be found here.
Shared Clinical Decision-Making and the Pharmacist's Role
02 Mar 2026
00:43:32
Recent changes to childhood vaccine recommendations have introduced shared clinical decision‑making for several immunizations that were previously universally recommended, creating confusion among patients and providers alike. This course explains what shared clinical decision‑making means in the context of immunizations, examines how it affects pediatric vaccine discussions, and highlights opportunities for pharmacists to support informed, individualized conversations with patients and caregivers. You will gain clarity on how to apply shared clinical decision‑making principles—alongside proven health coaching strategies—to strengthen patient trust and foster more meaningful dialogue in pharmacy practice.
HOST Rachel Maynard, PharmD GameChangers Podcast Host and Clinical Editor, CEimpact Lead Editor, Pyrls
GUEST Elizabeth Skoy, PharmD, RPh Professor North Dakota State University
GET CE FOR LISTENING! Stay Compliant. Grow Clinically. Practice with Confidence.
Pharmacist CE Subscription: All your CE in one convenient subscription. All episodes, CE, and Practice Resources for the GameChangers Clinical Update is included with your Pharmacist CE Subscription. But wait…there’s even more!
The Pharmacist CE Subscription includes: - Compliance and licensure CE - GameChangers Clinical Updates - Practical continuing education across patient care topics
*The subscription does not include microcredentials or certificates, which are available separately for pharmacists seeking specialized service training.
PRACTICE RESOURCE Receive the exclusive Practice Resource to use as a reference guide for this episode by purchasing the Pharmacist CE Subscription.
CPE REDEMPTION This course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation to claim credit:
CPE INFORMATION Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Describe shared clinical decision-making and how it applies to recent pediatric vaccine recommendations. 2. Identify the pharmacist's roles in counseling, education, and facilitating shared clinical decision-making conversations with patients and caregivers.
Rachel Maynard and Elizabeth Skoy have no relevant financial relationships with ineligible companies to disclose.
0.05 CEU/0.5 Hr UAN: 0107-0000-26-077-H01-P Initial release date: 3/2/2026 Expiration date: 3/2/2027 Additional CPE details can be found here.
As gabapentin climbs the ranks to become one of the most prescribed medications in the U.S., questions about its safety and scope of use are also rising. This episode explores recent trends in gabapentin use, highlights key patient safety concerns, and examines pharmacist-led opportunities to reduce risks through education and medication review. You will walk away with timely insights to help navigate the growing complexities and responsibilities associated with gabapentin use.
HOST Rachel Maynard, PharmD GameChangers Podcast Host and Clinical Editor, CEimpact Lead Editor, Pyrls
GUEST Nakia Duncan, PharmD BCGP, BCPS Associate Professor/ Pain& Palliative Care Clinical Pharmacist Texas Tech Health Science Center - School of Pharmacy
GET CE FOR LISTENING! Stay Compliant. Grow Clinically. Practice with Confidence.
Pharmacist CE Subscription: All your CE in one convenient subscription. All episodes, CE, and Practice Resources for the GameChangers Clinical Update is included with your Pharmacist CE Subscription. But wait…there’s even more!
The Pharmacist CE Subscription includes: - Compliance and licensure CE - GameChangers Clinical Updates - Practical continuing education across patient care topics
*The subscription does not include microcredentials or certificates, which are available separately for pharmacists seeking specialized service training.
PRACTICE RESOURCE Receive the exclusive Practice Resource to use as a reference guide for this episode by purchasing the Pharmacist CE Subscription.
CPE REDEMPTION This course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation to claim credit:
CPE INFORMATION Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Summarize recent national prescribing trends and safety concerns associated with gabapentin use. 2. Identify pharmacist-led strategies to support safe use, patient education, and medication review involving gabapentin.
Rachel Maynard and Nakia Duncan have no relevant financial relationships with ineligible companies to disclose.
0.05 CEU/0.5 Hr UAN: 0107-0000-26-053-H01-P Initial release date: 2/23/2026 Expiration date: 2/23/2027 Additional CPE details can be found here.
Recent updates to U.S. guidelines for HIV post‑exposure prophylaxis (PEP) provide modernized recommendations for both non‑occupational and occupational exposures — reflecting advances in antiretroviral therapy and evolving evidence. This course summarizes key changes, including preferred regimens, testing/follow‑up modifications, and special‑population considerations, and explores how these updates influence clinical practice. You will gain the practical knowledge needed to inform prompt PEP decision‑making, patient counseling, and care coordination.
HOST Rachel Maynard, PharmD GameChangers Podcast Host and Clinical Editor, CEimpact Lead Editor, Pyrls
GUEST Kenric Ware, Pharm D Clinical Associate Professor of Pharmacy Practice Mercer University
GET CE FOR LISTENING! Stay Compliant. Grow Clinically. Practice with Confidence.
Pharmacist CE Subscription: All your CE in one convenient subscription. All episodes, CE, and Practice Resources for the GameChangers Clinical Update is included with your Pharmacist CE Subscription. But wait…there’s even more!
The Pharmacist CE Subscription includes: - Compliance and licensure CE - GameChangers Clinical Updates - Practical continuing education across patient care topics
*The subscription does not include microcredentials or certificates, which are available separately for pharmacists seeking specialized service training.
PRACTICE RESOURCE Receive the exclusive Practice Resource to use as a reference guide for this episode by purchasing the Pharmacist CE Subscription.
CPE REDEMPTION This course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation to claim credit:
CPE INFORMATION Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Identify current guideline recommendations for initiating HIV PEP after occupational and non-occupational exposure. 2. Describe key considerations for selecting and managing HIV PEP regimens.
Rachel Maynard and Kenric Ware have no relevant financial relationships with ineligible companies to disclose.
0.05 CEU/0.5 Hr UAN: 0107-0000-26-052-H01-P Initial release date: 2/16/2026 Expiration date: 2/16/2027 Additional CPE details can be found here.
Recent developments in HIV prevention — including the FDA approval of a 6‑month injectable option and updated clinical guidance — are changing the landscape of Pre-Exposure Prophylaxis (PrEP) therapy. This course reviews the latest developments, compares prevention strategies, and examines how these changes affect PrEP delivery, counseling, and monitoring. You will gain timely insights to better counsel patients, support adherence, and contribute to prevention strategies in your practice.
HOST Rachel Maynard, PharmD GameChangers Podcast Host and Clinical Editor, CEimpact Lead Editor, Pyrls
GUEST David Hachey, PharmD, AAHIVP Professor Idaho State University
GET CE FOR LISTENING! Stay Compliant. Grow Clinically. Practice with Confidence.
Pharmacist CE Subscription: All your CE in one convenient subscription. All episodes, CE, and Practice Resources for the GameChangers Clinical Update is included with your Pharmacist CE Subscription. But wait…there’s even more!
The Pharmacist CE Subscription includes: - Compliance and licensure CE - GameChangers Clinical Updates - Practical continuing education across patient care topics
*The subscription does not include microcredentials or certificates, which are available separately for pharmacists seeking specialized service training.
PRACTICE RESOURCE Receive the exclusive Practice Resource to use as a reference guide for this episode by purchasing the Pharmacist CE Subscription.
CPE REDEMPTION This course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation to claim credit:
CPE INFORMATION Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Describe key new HIV PrEP therapy options recently approved or recommended, including their dosing schedules and clinical indications. 2. Identify pharmacist responsibilities when counseling patients about PrEP, including initiation, adherence, monitoring, and risk-benefit discussions.
Rachel Maynard and David Hachey have no relevant financial relationships to disclose.
0.05 CEU/0.5 Hr UAN: 0107-0000-26-049-H01-P Initial release date: 2/9/2026 Expiration date: 2/9/2027 Additional CPE details can be found here.
The Role of Biosimilars in Managing Inflammatory Disease
02 Feb 2026
00:42:12
With the number of biosimilar products steadily increasing, pharmacists play a central role in ensuring their appropriate use in inflammatory conditions. This episode highlights approval pathways, interchangeability, and real-world challenges pharmacists may face when integrating biosimilars into care plans. You will walk away better prepared to support prescribers, counsel patients, and contribute to cost-effective, evidence-informed therapy decisions.
HOST Rachel Maynard, PharmD GameChangers Podcast Host and Clinical Editor, CEimpact Lead Editor, Pyrls
GUEST Reemal Zaheer, PharmD, CSP Pharmacist Johns Hopkins Medicine
GET CE FOR LISTENING! Stay Compliant. Grow Clinically. Practice with Confidence.
Pharmacist CE Subscription: All your CE in one convenient subscription. All episodes, CE, and Practice Resources for the GameChangers Clinical Update is included with your Pharmacist CE Subscription. But wait…there’s even more!
The Pharmacist CE Subscription includes: - Compliance and licensure CE - GameChangers Clinical Updates - Practical continuing education across patient care topics
*The subscription does not include microcredentials or certificates, which are available separately for pharmacists seeking specialized service training.
PRACTICE RESOURCE Receive the exclusive Practice Resource to use as a reference guide for this episode by purchasing the Pharmacist CE Subscription.
CPE REDEMPTION This course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation to claim credit:
CPE INFORMATION Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Explain the role of biosimilars in the treatment of inflammatory conditions. 2. Describe considerations for the pharmacist when evaluating or counseling on biosimilar therapies.
Rachel Maynard and Reemal Zaheer have no relevant financial relationships with ineligible companies to disclose.
0.075 CEU/0.75 Hr UAN: 0107-0000-26-045-H01-P Initial release date: 2/2/2026 Expiration date: 2/2/2027 Additional CPE details can be found here.
FDA Removes Boxed Warnings on Menopausal Hormone Therapy
26 Jan 2026
00:41:37
Menopausal hormone therapy has long carried a boxed warning (formerly a "black box warning") that may not accurately reflect the therapy's risk-benefit profile for all patients. This course discusses the FDA's recent removal of boxed warnings for select hormone therapy (HT) products, the rationale for this change, and how evolving guidance may impact patient care. You will explore strategies to support evidence-based counseling and individualized decision-making for patients considering HT.
HOST Rachel Maynard, PharmD GameChangers Podcast Host and Clinical Editor, CEimpact Lead Editor, Pyrls
GUEST Erin Raney, PharmD Professor Midwestern University College of Pharmacy
GET CE FOR LISTENING! Stay Compliant. Grow Clinically. Practice with Confidence.
Pharmacist CE Subscription: All your CE in one convenient subscription. All episodes, CE, and Practice Resources for the GameChangers Clinical Update is included with your Pharmacist CE Subscription. But wait…there’s even more!
The Pharmacist CE Subscription includes: - Compliance and licensure CE - GameChangers Clinical Updates - Practical continuing education across patient care topics
*The subscription does not include microcredentials or certificates, which are available separately for pharmacists seeking specialized service training.
PRACTICE RESOURCE Receive the exclusive Practice Resource to use as a reference guide for this episode by purchasing the Pharmacist CE Subscription.
CPE REDEMPTION This course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation to claim credit:
CPE INFORMATION Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Summarize the FDA's updated position on boxed warnings for menopausal hormone therapy. 2. Identify key considerations for pharmacists when counseling patients about the benefits and risks of hormone therapy.
Rachel Maynard and Erin Raney have no relevant financial relationships with ineligible companies to disclose.
0.075 CEU/0.75 Hr UAN: 0107-0000-26-044-H01-P Initial release date: 1/26/2026 Expiration date: 1/26/2027 Additional CPE details can be found here.
Ranitidine — once withdrawn from the market over safety concerns — was recently re‑approved by the FDA in a reformulated version, raising important questions for pharmacists and patients alike. This course outlines the FDA’s recent approval, reviews the reformulated product's changes (including manufacturing and labeling), and examines practical considerations for dispensing, counseling, and patient safety. You will gain clarity on when ranitidine may be appropriate for use (again) and how to guide patients confidently in its safe use.
HOST Rachel Maynard, PharmD GameChangers Podcast Host and Clinical Editor, CEimpact Lead Editor, Pyrls
GUEST K. Ashley Garling-Nanez, PharmD Assistant Director of Program UT Center of Health Communications
GET CE FOR LISTENING! Stay Compliant. Grow Clinically. Practice with Confidence.
All episodes, CE, and Practice Resources for the GameChangers Clinical Update is included with your Pharmacist CE Subscription. But wait…there’s even more!
· Practical continuing education across patient care topics
*The subscription does not include microcredentials or certificates, which are available separately for pharmacists seeking specialized service training.
PRACTICE RESOURCE Receive the exclusive Practice Resource to use as a reference guide for this episode by purchasing the Pharmacist CE Subscription.
CPE REDEMPTION This course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation to claim credit:
CPE INFORMATION Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Summarize the major safety and regulatory issues that prompted ranitidine's withdrawal, and the changes made in the reformulated product approved in 2025. 2. Describe pharmacist‑relevant considerations for dispensing, patient counseling, and transition from alternative acid‑reducing therapies.
Rachel Maynard and K. Ashley Garling-Nanez have no relevant financial relationships with ineligible companies to disclose.
0.05 CEU/0.5 Hr UAN: 0107-0000-26-043-H01-P Initial release date: 1/19/2026 Expiration date: 1/19/2027 Additional CPE details can be found here.
Recent years have seen a troubling resurgence of whooping cough and measles — diseases many thought were largely controlled — highlighting the continuing importance of vaccination, surveillance, and community education. This course reviews the latest evidence on global and local trends, explores the factors driving renewed outbreaks, and discusses the key roles of pharmacists in prevention and early detection. You will gain insights to be better prepared to support immunization efforts, patient counseling, and public health awareness in response to this resurgence.
HOST Rachel Maynard, PharmD GameChangers Podcast Host and Clinical Editor, CEimpact Lead Editor, Pyrls
GUEST Christina O'Connor, PharmD, BCPS, BCIDP Clinical Pharmacy Manager Mayo Clinic
GET CE FOR LISTENING! Stay Compliant. Grow Clinically. Practice with Confidence.
All episodes, CE, and Practice Resources for the GameChangers Clinical Update is included with your Pharmacist CE Subscription. But wait…there’s even more!
· Practical continuing education across patient care topics
*The subscription does not include microcredentials or certificates, which are available separately for pharmacists seeking specialized service training.
PRACTICE RESOURCE Receive the exclusive Practice Resource to use as a reference guide for this episode by purchasing the Pharmacist CE Subscription.
CPE REDEMPTION This course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation to claim credit:
CPE INFORMATION Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Describe recent epidemiologic trends in pertussis and measles resurgence and factors contributing to increased incidence. 2. Identify the pharmacist's responsibilities for promoting vaccination, encouraging timely immunization, supporting outbreak prevention, and providing patient education.
Rachel Maynard and Christina O'Connor have no relevant financial relationships to disclose.
0.075 CEU/0.75 Hr UAN: 0107-0000-26-038-H01-P Initial release date: 1/12/2026 Expiration date: 1/12/2027 Additional CPE details can be found here.
Corticosteroids in the treatment of community-acquired pneumonia (CAP) remain a topic of clinical curiosity and mixed opinions. In this unique episode, two expert guests share opposing perspectives—one advocating for corticosteroid use in CAP and the other urging caution—offering pharmacists a balanced view of the current evidence and practice considerations. Tune in to explore both sides of the debate and walk away with insights to inform your role in collaborative patient care.
HOST Rachel Maynard, PharmD GameChangers Podcast Host and Clinical Editor, CEimpact Lead Editor, Pyrls
GUESTS Sam Markle, PharmD Critical Care Pharmacist Sanford Health
Tristan Houle, PharmD PGY2 Critical Care Pharmacy Resident Sanford Health
GET CE FOR LISTENING! Stay Compliant. Grow Clinically. Practice with Confidence.
All episodes, CE, and Practice Resources for the GameChangers Clinical Update is included with your Pharmacist CE Subscription. But wait…there’s even more!
· Practical continuing education across patient care topics
*The subscription does not include microcredentials or certificates, which are available separately for pharmacists seeking specialized service training.
PRACTICE RESOURCE Receive the exclusive Practice Resource to use as a reference guide for this episode by purchasing the Pharmacist CE Subscription.
CPE REDEMPTION This course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation to claim credit:
CPE INFORMATION Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Describe current evidence supporting and challenging the use of corticosteroids in the treatment of community-acquired pneumonia (CAP). 2. Identify key considerations for pharmacists when evaluating corticosteroid use as adjunctive therapy in CAP.
Rachel Maynard, Sam Markle, and Tristan Houle have no relevant financial relationships to disclose.
0.05 CEU/0.5 Hr UAN: 0107-0000-26-032-H01-P Initial release date: 1/5/2026 Expiration date: 1/5/2027 Additional CPE details can be found here.
As cannabis becomes more widely available and socially accepted, so does the misconception that it's safe to use during pregnancy and lactation. This course reviews updated guidance from the American College of Obstetricians and Gynecologists (ACOG), highlighting the evidence behind the risks and outlining how pharmacists can address misinformation and counsel patients effectively. You will learn how to support safe, informed decision-making that promotes the health of both parent and child.
HOST Rachel Maynard, PharmD GameChangers Podcast Host and Clinical Editor, CEimpact Lead Editor, Pyrls
GUEST Kevin Shea, PharmD Pharmacist Vytal Options
GET CE FOR LISTENING! Stay Compliant. Grow Clinically. Practice with Confidence.
All episodes, CE, and Practice Resources for the GameChangers Clinical Update is included with your Pharmacist CE Subscription. But wait…there’s even more!
· Practical continuing education across patient care topics
*The subscription does not include microcredentials or certificates, which are available separately for pharmacists seeking specialized service training.
PRACTICE RESOURCE Receive the exclusive Practice Resource to use as a reference guide for this episode by purchasing the Pharmacist CE Subscription.
CPE REDEMPTION This course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation to claim credit:
CPE INFORMATION Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Identify current ACOG recommendations regarding cannabis use during pregnancy and lactation. 2. Describe pharmacist strategies for screening, counseling, and reducing risks associated with cannabis use during the perinatal period.
Rachel Maynard and Kevin Shea have no relevant financial relationships to disclose.
Recent preclinical studies highlight the potential of micro‑dosed lithium to modulate Alzheimer’s disease pathology and support neuronal health. This episode examines the molecular mechanisms, current evidence in Alzheimer’s models, and emerging considerations for safe use and monitoring. You will gain insights to navigate this evolving topic and support informed discussions around lithium micro‑dosing in Alzheimer’s care.
HOST Rachel Maynard, PharmD GameChangers Podcast Host and Clinical Editor, CEimpact Lead Editor, Pyrls
GUEST Dawn Gerber, PharmD, BCGP, FASCP, FAzPA, CPAFH Professor of Pharmacy Practice Midwestern University
GET CE FOR LISTENING! Stay Compliant. Grow Clinically. Practice with Confidence.
All episodes, CE, and Practice Resources for the GameChangers Clinical Update is included with your Pharmacist CE Subscription. But wait…there’s even more!
· Practical continuing education across patient care topics
*The subscription does not include microcredentials or certificates, which are available separately for pharmacists seeking specialized service training.
PRACTICE RESOURCE Receive the exclusive Practice Resource to use as a reference guide for this episode by purchasing the Pharmacist CE Subscription.
CPE REDEMPTION This course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation to claim credit:
CPE INFORMATION Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Describe current evidence on the use of microdose lithium in Alzheimer's disease. 2. Identify pharmacist considerations for monitoring, patient selection, and safety in the context of lithium micro-dosing for Alzheimer's.
Rachel Maynard and Dawn Gerber have no relevant financial relationships to disclose.
0.05 CEU/0.5 Hr UAN: 0107-0000-25-375-H01-P Initial release date: 12/22/2025 Expiration date: 12/22/2026 Additional CPE details can be found here.
New Prescription Option for Fibromyalgia Treatment
15 Dec 2025
00:45:44
Patients with fibromyalgia have waited more than a decade for a new therapeutic option, and a recent regulatory approval signals a shift for these patients. This episode reviews the clinical trial data, mechanism of action, dosing considerations, and pharmacist‑relevant monitoring for the newly approved sublingual formulation of cyclobenzaprine HCl. You will gain practical insights to inform patient education, therapy optimization, and interdisciplinary collaboration in fibromyalgia care.
HOST Rachel Maynard, PharmD GameChangers Podcast Host and Clinical Editor, CEimpact Lead Editor, Pyrls
All episodes, CE, and Practice Resources for the GameChangers Clinical Update is included with your Pharmacist CE Subscription. But wait…there’s even more!
· Practical continuing education across patient care topics
*The subscription does not include microcredentials or certificates, which are available separately for pharmacists seeking specialized service training.
PRACTICE RESOURCE Receive the exclusive Practice Resource to use as a reference guide for this episode by purchasing the Pharmacist CE Subscription.
CPE REDEMPTION This course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation to claim credit:
CPE INFORMATION Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Describe the mechanism of action and key clinical trial outcomes associated with the newly approved prescription medication for fibromyalgia. 2. Identify pharmacist responsibilities for dosing, monitoring adverse effects, and patient counseling when supporting the use of this new fibromyalgia therapy.
Rachel Maynard and Amanda (Mandy) Mullins have no relevant financial relationships with ineligible companies to disclose.
0.05 CEU/0.5 Hr UAN: 0107-0000-25-371-H01-P Initial release date: 12/15/2025 Expiration date: 12/15/2026 Additional CPE details can be found here.
How OTC Pain Medications May Fuel Antibiotic Resistance
08 Dec 2025
00:38:03
Pain relief medications like acetaminophen and ibuprofen are staples in everyday care—but emerging research suggests they may play a role in antibiotic resistance. This episode reviews recent findings, explores how these common drugs may influence bacterial response to antibiotics, and highlights pharmacist‑specific considerations. You will walk away with practical insights to support informed medication use and strengthen antibiotic stewardship.
HOST Rachel Maynard, PharmD GameChangers Podcast Host and Clinical Editor, CEimpact Lead Editor, Pyrls
Hunter O. Rondeau, PharmD, BCIDP, AAHIVP Antimicrobial Stewardship Coordinator, SSM Health Adjunct Clinical Assistant Professor, University of Kansas School of Pharmacy
Rachel Maynard has no relevant financial relationships with ineligible companies to disclose.
Hunter Rondeau is a consultant for Pyrls, a speaker for ASHP, and was a speaker for ACCP (ended October 2025) and Vituity (ended May 2025). All relevant financial relationships have been mitigated.
GET CE FOR LISTENING! Stay Compliant. Grow Clinically. Practice with Confidence.
All episodes, CE, and Practice Resources for the GameChangers Clinical Update is included with your Pharmacist CE Subscription. But wait…there’s even more!
· Practical continuing education across patient care topics
*The subscription does not include microcredentials or certificates, which are available separately for pharmacists seeking specialized service training.
PRACTICE RESOURCE Receive the exclusive Practice Resource to use as a reference guide for this episode by purchasing the Pharmacist CE Subscription.
CPE REDEMPTION This course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation to claim credit:
CPE INFORMATION Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Describe emerging evidence on how common OTC pain medications may influence antibiotic resistance. 2. Identify pharmacist strategies to optimize analgesic and antibiotic use while supporting antimicrobial stewardship.
0.05 CEU/0.5 Hr UAN: 0107-0000-25-372-H01-P Initial release date: 12/8/2025 Expiration date: 12/8/2026 Additional CPE details can be found here.
Recent FDA actions have brought renewed attention to leucovorin as a potential treatment for managing symptoms associated with autism spectrum disorder. This course explores the clinical distinctions between autism and cerebral folate deficiency, reviews key evidence behind leucovorin use, and outlines counseling considerations relevant to pharmacy practice. You will gain clarity on this complex and evolving topic to better support informed, evidence-based care.
HOST Rachel Maynard, PharmD GameChangers Podcast Host and Clinical Editor, CEimpact Lead Editor, Pyrls
GUEST Geoff Wall, PharmD, FCCP, BCPS Professor of Pharmacy Practice Iowa Methodist Medical Center
Rachel Maynard and Geoff Wall have no relevant financial relationships to disclose.
GET CE FOR LISTENING! Stay Compliant. Grow Clinically. Practice with Confidence.
All episodes, CE, and Practice Resources for the GameChangers Clinical Update is included with your Pharmacist CE Subscription. But wait…there’s even more!
· Practical continuing education across patient care topics
*The subscription does not include microcredentials or certificates, which are available separately for pharmacists seeking specialized service training.
PRACTICE RESOURCE Receive the exclusive Practice Resource to use as a reference guide for this episode by purchasing the Pharmacist CE Subscription.
CPE REDEMPTION This course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation to claim credit:
CPE INFORMATION Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Describe current clinical evidence related to the use of leucovorin in autism and cerebral folate deficiency. 2. Identify key counseling considerations for pharmacists discussing leucovorin therapy with patients and caregivers.
0.05 CEU/0.5 Hr UAN: 0107-0000-25-363-H01-P Initial release date: 12/1/2025 Expiration date: 12/1/2026 Additional CPE details can be found here.
Antibiotic Essentials - New Approvals and Clinical Refreshers
24 Nov 2025
00:41:54
Pharmacists play a critical role in infectious disease care, and staying up to date on antibiotic therapies is key to ensuring optimal patient outcomes. This episode reviews recently FDA-approved antibiotics, offers a practical refresher on commonly used antibiotic classes, and highlights frequent side effects—along with strategies for managing them in practice. Tune in to strengthen your clinical knowledge and support safe, effective antibiotic use across care settings.
HOST Joshua Davis Kinsey, PharmD VP, Education CEimpact
Joshua Davis Kinsey has no relevant financial relationships with ineligible companies to disclose.
Hunter Rondeau is a consultant for Pyrls, a speaker for ASHP, and was a speaker for ACCP (ended October 2025) and Vituity (ended May 2025). All relevant financial relationships have been mitigated.
CPE REDEMPTION This course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation:
CPE INFORMATION Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Identify newly FDA-approved antibiotics and their clinical indications. 2. Describe commonly used antibiotic classes, their typical side effects, and strategies to manage or mitigate those effects.
0.05 CEU/0.5 Hr UAN: 0107-0000-25-362-H01-P Initial release date: 11/24/2025 Expiration date: 11/24/2026 Additional CPE details can be found here.
Pharmacy's Role with Long-Acting Injectable Medications
17 Nov 2025
00:34:07
Discover the benefits of implementing a long-acting injectable (LAI) service at your pharmacy practice site and the impact this service can have on patient care and outcomes. Listen to this week’s episode and learn how to elevate your pharmacy services!
HOST Joshua Davis Kinsey, PharmD VP, Education CEimpact
GUEST Lindsay McCoy, PharmD, BCPP Pharmacy Manager Village Drug Shop at Advantage
CPE REDEMPTION This course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation:
CPE INFORMATION Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Analyze the benefits and challenges of implementing a long-acting injectable (LAI) service in a pharmacy practice site. 2. Discuss how an LAI service can improve patient care, increase financial sustainability, and optimize patient outcomes.
0.05 CEU/0.5 Hr UAN: 0107-0000-25-354-H01-P Initial release date: 11/17/2025 Expiration date: 11/17/2026 Additional CPE details can be found here.
Take your pharmacy practice to the next level with our comprehensive course on the administration of long-acting injectables: Pharmacy-Based Administration of Long-Acting Injectables: A Sharp Idea 4 hours | On Demand Explore a cutting edge clinical service opportunity with this collection of courses specifically designed to equip pharmacists with the knowledge and skills necessary for the effective management and administration of long-acting injectable medications (LAIs). Course content explores diverse drug profiles, advanced administration techniques, and the strategic implementation of LAI-related services to support the needs of your patients and communities.